Intercept Pharma (ICPT) Receives Final Approval for Securities Class Action Settlement
Tweet Send to a Friend
Intercept Pharma (Nasdaq: ICPT) disclosed the following in a U.S. SEC filing on Monday:Item 8.01 Other Events.On September 8, 2016 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
